Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents		$ 123,575	$ 105,597
Marketable securities		196,049	264,930
Prepaid expenses and other current assets		8,577	9,067
Total current assets		328,201	379,594
Restricted cash		1,585	1,690
Marketable securities, non-current		0	13,014
Other investments		19,000	19,000
Property and equipment, net		36,722	48,200
Operating lease right-of-use assets		19,912	24,739
Other non-current assets		2,545	4,622
Total assets		407,965	490,859
Current liabilities:
Accounts payable		2,568	5,366
Accrued liabilities and other current liabilities		29,310	40,822
Contingent consideration payable		0	7,600
Total current liabilities		31,878	53,788
Operating lease liabilities, non-current		44,285	50,994
Other non-current liabilities		2,681	3,253
Total liabilities		78,844	108,035
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000 shares authorized at September 30, 2025 and December 31, 2024; no shares issued and outstanding at September 30, 2025 and December 31, 2024		0	0
Common stock, value, issued	[1]	2	1
Additional paid-in capital	[1]	1,807,749	1,727,638
Accumulated other comprehensive income		201	291
Accumulated deficit		(1,478,831)	(1,345,106)
Total stockholders’ equity		329,121	382,824	[2]
Total liabilities and stockholders’ equity		$ 407,965	$ 490,859

[1] Amounts previously reported have been retroactively adjusted to reflect the 1-for-20 reverse stock split effected on May 30, 2025. See Note 2.

[2] Amounts previously reported for common stock and additional paid-in-capital have been adjusted to reflect the 1-for-20 reverse stock split effected on May 30, 2025. See Note 2.